ReP USP - Resultado da busca

Filtros : "Amarin" Limpar

Filtros

USP affiliated authors
- nicolau, josé carlos (~1)
- santos filho, raul dias dos (~1)
Date published
- 2025 (~1)
- 2018 (~1)
Subjects
- doenças cardiovasculares (2)
- acidente vascular cerebral (1)
- colesterol (1)
- diabetes mellitus (1)
- fármacos do sangue e sistema hematopoético (1)

Artigo de periodico
Expanding the triglyceride range in clinical trials: therapeutic opportunities (2025)
Nordestgaard, Ask T.; Pradhan, Aruna D.; Everett, Brendan M.; Macfadyen, Jean G.; Bhatt, Deepak L.; Visseren, Frank L. J.; Libby, Peter; Santos Filho, Raul Dias dos ; Nissen, Steven E.; Nordestgaard, Borge G.
Source: European Heart Journal. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES, INFARTO DO MIOCÁRDIO, COLESTEROL, ACIDENTE VASCULAR CEREBRAL, LIPOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NORDESTGAARD, Ask T. et al. Expanding the triglyceride range in clinical trials: therapeutic opportunities. European Heart Journal, v. 46, n. 19, p. 1835-1848, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/87137. Acesso em: 27 jan. 2026.
APA
Nordestgaard, A. T., Pradhan, A. D., Everett, B. M., Macfadyen, J. G., Bhatt, D. L., Visseren, F. L. J., et al. (2025). Expanding the triglyceride range in clinical trials: therapeutic opportunities. European Heart Journal, 46( 19), 1835-1848. doi:10.1093/eurheartj/ehaf074
NLM
Nordestgaard AT, Pradhan AD, Everett BM, Macfadyen JG, Bhatt DL, Visseren FLJ, Libby P, Santos Filho RD dos, Nissen SE, Nordestgaard BG. Expanding the triglyceride range in clinical trials: therapeutic opportunities [Internet]. European Heart Journal. 2025 ; 46( 19): 1835-1848.[citado 2026 jan. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87137
Vancouver
Nordestgaard AT, Pradhan AD, Everett BM, Macfadyen JG, Bhatt DL, Visseren FLJ, Libby P, Santos Filho RD dos, Nissen SE, Nordestgaard BG. Expanding the triglyceride range in clinical trials: therapeutic opportunities [Internet]. European Heart Journal. 2025 ; 46( 19): 1835-1848.[citado 2026 jan. 27 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87137
Artigo de periodico
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) (2018)
Giugliano, Robert P.; Nicolau, Jose Carlos
Source: Circulation. Unidade: FM
Subjects: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIUGLIANO, Robert P. e NICOLAU, Jose Carlos. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, v. 137, n. 15, p. 1571-0, 2018Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.117.030950. Acesso em: 27 jan. 2026.
APA
Giugliano, R. P., & Nicolau, J. C. (2018). Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, 137( 15), 1571-0. doi:10.1161/CIRCULATIONAHA.117.030950
NLM
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Vancouver
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2026